Uhlenhuth E H, Johanson C E, Kilgore K, Kobasa S C
Psychopharmacology (Berl). 1981;74(2):191-4. doi: 10.1007/BF00432692.
Forty-five normal, young, adult volunteers participated in a nine-session experiment. During the first four sessions, they received alternately 5 mg d-amphetamine or placebo. During the next five sessions, they chose between amphetamine and placebo. On the basis of the choice results, subjects retrospectively were divided into the following three groups: (1) five of five drug choices (N = 16); (2) four of five drug choices (N = 12); and (3) 0--3 of five drug choices (N = 17). There was an overall average of 3.76 drug choices per subject. These groups were compared by demographic characteristics, drug use history, and several personality measures, but none predicted drug choice. However, subjects who chose drug on every occasion had significantly higher predrug scores on the anxiety, depression, and confusion subscales of the Profile of Mood States (POMS). The functional relationship between initial dysphoria and consistent amphetamine choosing remains an intriguing question.
45名正常、年轻的成年志愿者参与了一项为期九节的实验。在前四节实验中,他们交替服用5毫克右旋苯丙胺或安慰剂。在接下来的五节实验中,他们在苯丙胺和安慰剂之间进行选择。根据选择结果,受试者被回顾性地分为以下三组:(1)五次药物选择均为药物(N = 16);(2)五次药物选择中有四次为药物(N = 12);(3)五次药物选择中有0 - 3次为药物(N = 17)。每位受试者药物选择的总体平均次数为3.76次。通过人口统计学特征、药物使用史和多项人格测量对这些组进行了比较,但没有一项能够预测药物选择。然而,每次都选择药物的受试者在情绪状态剖面图(POMS)的焦虑、抑郁和困惑分量表上的用药前得分显著更高。初始烦躁不安与持续选择苯丙胺之间的功能关系仍然是一个有趣的问题。